Wei-Jen Tang Selected Research

Wei-Jen Tang Research Topics

Disease

22	Anthrax 01/2019 - 01/2002
10	Edema (Dropsy) 01/2019 - 04/2005
9	Alzheimer Disease (Alzheimer's Disease) 12/2019 - 08/2007
6	Whooping Cough (Pertussis) 04/2012 - 12/2002
5	Infections 12/2010 - 08/2004
4	Inflammation (Inflammations) 01/2018 - 04/2008
3	Neoplasms (Cancer) 11/2008 - 02/2004
2	Disease Progression 01/2021 - 10/2016
2	Glucose Intolerance 09/2015 - 10/2006
1	Tuberculosis (Tuberculoses) 01/2021
1	Nervous System Diseases (Neurological Disorders) 12/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2016
1	Leukemia 10/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Neuroblastoma 05/2014
1	Diabetes Mellitus 05/2010
1	Toxemia 03/2009
1	Breast Neoplasms (Breast Cancer) 10/2008
1	Ovarian Neoplasms (Ovarian Cancer) 10/2008
1	Pulmonary Edema 06/2008
1	Lymphopenia (Lymphocytopenia) 06/2008
1	Shock 06/2008
1	Hemorrhage 06/2008
1	Hypotension (Low Blood Pressure) 05/2007
1	Chronic Hepatitis B 03/2004
1	Persistent Infection 03/2004
1	Carcinogenesis 02/2004
1	Necrosis 02/2004

Drug/Important Bio-Agent (IBA)

18	Adenylyl Cyclases (Adenylyl Cyclase)IBA 07/2015 - 01/2002
13	edema factorIBA 07/2015 - 12/2002
10	Insulysin (Insulin-Degrading Enzyme)IBA 01/2018 - 08/2007
8	Calmodulin (Calcium-Dependent Activator Protein)IBA 07/2015 - 01/2002
6	anthrax toxin (anthrax lethal factor)IBA 01/2019 - 03/2004
6	ExotoxinsIBA 01/2019 - 01/2002
6	Peptides (Polypeptides)IBA 01/2018 - 08/2007
6	Virulence Factors (Pathogenicity Factors)IBA 04/2012 - 03/2004
5	Insulin (Novolin)FDA Link 01/2018 - 08/2007
5	AntigensIBA 11/2010 - 02/2005
4	EnzymesIBA 01/2021 - 10/2008
4	Metalloproteases (Metalloproteinases)IBA 01/2021 - 08/2007
4	Amyloid (Amyloid Fibrils)IBA 01/2018 - 02/2011
4	Amyloid beta-PeptidesIBA 05/2014 - 10/2006
4	Proteins (Proteins, Gene)FDA Link 04/2012 - 05/2007
4	CytokinesIBA 06/2008 - 03/2004
2	ZincIBA 01/2021 - 08/2007
2	Adenylate Cyclase ToxinIBA 04/2012 - 12/2009
2	Pyrimidine NucleotidesIBA 08/2009 - 03/2009
2	purineIBA 08/2009 - 03/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2009 - 06/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2005 - 02/2004
1	Neutralizing AntibodiesIBA 01/2019
1	Phosphotransferases (Kinase)IBA 10/2016
1	ibrutinibIBA 10/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2016
1	CC ChemokinesIBA 05/2016
1	LigandsIBA 05/2016
1	ChemokinesIBA 12/2010
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 12/2010
1	Peptide Hormones (Polypeptide Hormones)IBA 05/2010
1	Glucose (Dextrose)FDA LinkGeneric 05/2010
1	CholesterolIBA 05/2009
1	PerforinIBA 05/2009
1	Hemoglobins (Hemoglobin)IBA 06/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2008
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2008
1	Glycoproteins (Glycoprotein)IBA 08/2007
1	erythromycin propionate-N-acetylcysteinateIBA 07/2007
1	Interleukin-10 (Interleukin 10)IBA 04/2005
1	Antigen Receptors (Antigen Receptor)IBA 02/2005
1	Indicators and Reagents (Reagents)IBA 08/2004
1	diphosphoric acid (pyrophosphoric acid)IBA 07/2004
1	adefovir dipivoxil (Hepsera)FDA Link 03/2004
1	adefovirIBA 03/2004
1	NF-kappa B (NF-kB)IBA 02/2004
1	AntitoxinsIBA 07/2003
1	factor AIBA 01/2002

Therapy/Procedure

3	Therapeutics 01/2019 - 02/2004
1	Intravenous Infusions 05/2007